Most Common Side Effects of Atorvastatin
The most common side effects of atorvastatin are nasal congestion/sore throat/runny nose, diarrhea, urinary tract infection, nausea, muscle spasms, throat pain, muscle and joint pain, pain in extremities, upset stomach, musculoskeletal pain, and trouble sleeping 1.
Frequency and Clinical Significance
According to FDA labeling, these common side effects occur in ≥5% of patients and are generally mild 1. The overall withdrawal rate due to adverse events is remarkably low at only 2-3% across clinical trials 2, 3, indicating that most patients tolerate atorvastatin well despite experiencing these symptoms.
Serious Adverse Effects to Monitor
While less common, three serious adverse effects require clinical vigilance:
Muscle-Related Problems (Myopathy)
- Unexplained muscle pain, tenderness, or weakness should prompt immediate evaluation 1
- Risk increases with higher doses, age ≥65 years, renal impairment, hypothyroidism, and certain drug interactions 4, 1
- Check creatine kinase (CK) levels before starting therapy and when symptoms occur 4
- True myopathy with persistent CK elevation >10x upper limit of normal is rare (0.01% in pooled trials) 2
Liver Function Abnormalities
- Persistent transaminase elevations >3x upper limit of normal occur in approximately 0.5-0.7% of patients 2, 3
- Most elevations occur within the first 16 weeks of treatment 3
- Check liver enzymes at baseline, at 12 weeks, then annually 4
- Discontinue if jaundice, dark urine, or persistent nausea/vomiting develop 1
Increased Blood Sugar
- Blood glucose may increase during treatment 1
- This effect is dose-dependent and confirmed in blinded trials 5
Evidence Quality and Context
The safety profile is based on extensive data from 44 completed trials involving 9,416 atorvastatin-treated patients 2. A recent 2026 meta-analysis of double-blind randomized trials found that most adverse effects listed in product labels lack causal evidence from blinded studies 5. Specifically, conditions like cognitive impairment, depression, sleep disturbance, and peripheral neuropathy were not significantly increased in blinded trials despite being listed in product labeling 5.
Gastrointestinal Effects
While flatulence, dyspepsia, constipation, and abdominal discomfort are commonly reported in observational studies 6, meta-analyses of clinical trials show no significant difference in gastrointestinal adverse effects between statin-treated and placebo groups 6. This suggests reporting bias in unblinded settings.
Clinical Pitfalls to Avoid
- Don't routinely monitor CK levels unless patients report muscle symptoms 4
- Don't attribute every symptom to the statin - blinded trial data show many reported effects are not causally related 5
- Don't exceed the dose needed to reach lipid goals, as adverse effects are dose-dependent 4
- Avoid grapefruit juice >1.2 liters daily as it increases atorvastatin levels 1